未登录

I

Ivar Sønbø Kristiansen

Institute of Health and Society

H指数:35

被引数:4,203

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cost-effectiveness of low-dose CT lung cancer screening among individuals that have ever smoked in Norway: A model-based analysis using NELSON trial criteria and outcomes

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2025-12-010

PRE

Ten-year costs of cardiovascular disease in genetically verified familial hypercholesterolaemia compared with age- and sex-matched controls

与年龄和性别匹配的对照组相比，经基因验证的家族性高胆固醇血症的十年心血管疾病成本

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY

IF7.5

2025-10-010

OAAI

Medical costs of treating myasthenia gravis in patients who need intravenous immunoglobulin (IVIg) – a register-based study

Journal of Neurology

IF4.6

2024-12-120

OAAI

NO INCREASED ALL-CAUSE MORTALITY IN GENETICALLY VERIFIED FAMILIAL HYPERCHOLESTEROLEMIA

ATHEROSCLEROSIS

IF5.7

2024-12-010

PRE

Treatment with PCSK9 monoclonal antibodies is associated with discontinuation of oral lipid lowering therapy

EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES

IF4.6

2024-11-191

OA

High discontinuation rate of statins among PCSK9i users: a nationwide study from 2015-2023

EUROPEAN HEART JOURNAL

IF35.6

2024-10-280

PRE

Danish Women Make Decisions about Participation in Breast Cancer Screening prior to Invitation Information: An Online Survey Using Experimental Methods

MEDICAL DECISION MAKING

IF2.3

2024-05-040

OA

Increasing melanoma incidence with unchanged mortality: more sunshine, better treatment, increased diagnostic activity, overdiagnosis or lowered diagnostic threshold?

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2024-04-243

OA

Intravitreal anti-vascular endothelial growth factor therapy for retinal diseases in Norway from 2011 to 2021: A combined registry and survey study

ACTA OPHTHALMOLOGICA

IF2.8

2023-12-091

OA

Danish Women Want to Participate in a Hypothetical Breast Cancer Screening with Harms and No Reduction in Mortality: A Cross-Sectional Survey

MEDICAL DECISION MAKING

IF2.3

2023-02-034

PRE

Prolongation of disease-free life: When is the benefit sufficient to warrant the effort of taking a preventive medicine?

PREVENTIVE MEDICINE

IF3.2

2022-01-011

OAAI

Societal cost of cancer in Norway -Results of taking a broader cost perspective

IF3.4

2021-08-017

PREAI

Re: Stage-specific survival has improved for young breast cancer patients since 2000: but not equally?

BREAST CANCER RESEARCH AND TREATMENT

IF3

2020-09-240

PREAI

Intravitreal therapy for retinal diseases in Norway 2011-2015

ACTA OPHTHALMOLOGICA

IF2.8

2019-10-069

OAAI

Economic evaluation of lipid lowering with PCSK9 inhibitors in patients with familial hypercholesterolemia: Methodological aspects

ATHEROSCLEROSIS

IF5.7

2019-08-019

OAAI

The healthcare costs of treating human papillomavirus-related cancers in Norway

IF3.4

2019-05-076

OAAI

Predicting Difference in Mean Survival Time from Reported Hazard Ratios for Cancer Patients

MEDICAL DECISION MAKING

IF2.3

2019-03-055

PREAI

Effect of organized mammography screening on breast cancer mortality: A population-based cohort study in Norway

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2018-10-2215

OAAI

General population norms for the EQ-5D-3L in Norway: comparison of postal and web surveys

挪威EQ-5D-3L的一般人口规范: 邮政和网络调查的比较

HEALTH AND QUALITY OF LIFE OUTCOMES

IF3.4

2018-10-1939

OAAI

THE IMPACT OF AGE AND SEX ON EXCESS RISK OF CORONARY HEART DISEASE IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA: A REGISTRY STUDY

ATHEROSCLEROSIS

IF5.7

2018-08-010

PREAI